Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
A number of Britons are feared stranded on Mount Everest after the Nepal earthquake triggered a deadly avalanche on Saturday.
Emma Jesson brings you Saturday night's forecast
Feeling much colder later on Saturday. Wintry showers possible on Sunday and Monday